Procurement Summary
Country: Brazil
Summary: Miscellaneous Medicines (Other Classes)
Deadline: 03 Feb 2026
Posting Date: 21 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 134073479
Document Ref. No.: 94143/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Miscellaneous Medicines (Other Classes) UASG code: 984123 Notice from: 01/21/2026 from 08:00 to 17:59 Proposal Delivery: from 01/21/2026 at 08:00 SOLIFENACIN, SUCCINATE SALT COMPOSITION, CONCENTRATION 5 MG Quantity: 540 MIRABEGRONA, CONCENTRATION 50 MG, ADDITIONAL PROLONGED RELEASE Quantity: 1620 FINASTERIDE, COMPOSITION ASSOCIATED WITH DOXAZOSIN MESYLATE, CONCENTRATION 5 MG + 2MG Quantity: 540 POTASSIUM CITRATE, CONCENTRATION 10 MEQ, PHARMACEUTICAL FORM DELAYED ABSORPTION Quantity: 2160 TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 36 TESTOSTERONE, UNDECYLATE SALT COMPOSITION, CONCENTRATION 250 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 36 GLUCAGON, DOSAGE 1 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 18 LEVOTHYROXINE SODIUM, CONCENTRATION 62.5 MCG Quantity: 540 TIAMAZOLE, DOSAGE 5 MG Quantity: 810 TERIPARATE, CONCENTRATION 250 MCG/ML, FORM PHARMACEUTICAL INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 41 TERIPARATE, CONCENTRATION 250 MCG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 13 ZINC OXIDE, ACTIVE INGREDIENT ASSOCIATED WITH VITAMIN A + VITAMIN D, CONCENTRATION 100 MG + 1, 000 IU + 400 IU/G, PHARMACEUTICAL OINTMENT FORM Quantity: 252 DEXPANTENOL, CONCENTRATION 50 MG/G, CREAM PHARMACEUTICAL FORM, ADDITIONAL SPECIALLY HANDLED FORMULATION Quantity: 540 NYSTATIN, COMPOSITION ASSOCIATED WITH ZINC OXIDE, CONCENTRATION 100, 000UI + 200 MG/G, CREAM PHARMACEUTICAL FORM, SPECIALLY HANDLED ADDITIONAL CHARACTERISTICS Quantity: 360 COLAGENASE, CONCENTRATION 0.6UI/G, USE OINTMENT Quantity: 18 TACROLIMO, DOSAGE 1 MG/G, PHARMACEUTICAL FORM OINTMENT Quantity: 18 TIZA...
Documents
Tender Notice